Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Karl Rickels
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Procedures
Disorders
Concepts & Ideas
Chemicals & Drugs
Devices
Sign-in to see full Profile
Network (preview)
54
Schweizer, Edward
21
Freeman, Ellen
16
Rynn, Moira
15
Sondheimer, Steven
10
DeMartinis, N
9
Mandos, Laura
6
Amsterdam, Jay
5
García-España, Felipe
4
Lucki, Irwin
4
Greenblatt, David
3
Lydiard, Bruce
3
Polansky, Marcia
3
Zimbroff, Dan
3
Garcia-España, Felipe
2
Iyengar, Malini
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Karl Rickels (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Freeman Ellen W; Rickels Karl; Sammel Mary D; Lin Hui; Sondheimer Steven J
Time to relapse after short- or long-term treatment of severe premenstrual syndrome with sertraline.
Archives of general psychiatry 2009;66(5):537-44.
-
2009: Rickels Karl; Robinson Donald S
Comments on "Clinical trials of antidepressants: time to shift to a new model" by Dr Katz.
Journal of clinical psychopharmacology 2009;29(2):197-8; author reply 198-9.
-
2009: Rickels Michael R; Khalid-Khan Sarosh; Gallop Robert; Rickels Karl
Assessment of anxiety and depression in primary care: value of a four-item questionnaire.
The Journal of the American Osteopathic Association 2009;109(4):216-9.
-
2009: Rickels Karl; Athanasiou Maria; Robinson Donald S; Gibertini Michael; Whalen Heidi; Reed Carol R
Evidence for efficacy and tolerability of vilazodone in the treatment of major depressive disorder: a randomized, double-blind, placebo-controlled trial.
The Journal of clinical psychiatry 2009;70(3):326-33.
-
2008: Garakani Amir; Martinez Jose M; Marcus Sue; Weaver James; Rickels Karl; Fava Maurizio; Hirschowitz Jack
A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder.
International clinical psychopharmacology 2008;23(5):269-75.
-
2008: Lohoff Falk W; Rickels Karl
Desvenlafaxine succinate for the treatment of major depressive disorder.
Expert opinion on pharmacotherapy 2008;9(12):2129-36.
-
2008: Rickels Karl; Garcia-Espana Felipe; Mandos Laura A; Case George W
Physician Withdrawal Checklist (PWC-20).
Journal of clinical psychopharmacology 2008;28(4):447-51.
-
2008: Rickels Karl; Mathew Sanjay; Banov Michael D; Zimbroff Daniel L; Oshana Scott; Parsons Edward C; Donahue Stephen R; Kauffman Michael; Iyer Ganesh R; Reinhard John F
Effects of PRX-00023, a novel, selective serotonin 1A receptor agonist on measures of anxiety and depression in generalized anxiety disorder: results of a double-blind, placebo-controlled trial.
Journal of clinical psychopharmacology 2008;28(2):235-9.
-
2008: Rynn Moira; Russell James; Erickson Janelle; Detke Michael J; Ball Susan; Dinkel Jeff; Rickels Karl; Raskin Joel
Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial.
Depression and anxiety 2008;25(3):182-9.
-
2007: Dunlop Boadie W; Crits-Christoph Paul; Evans Dwight L; Hirschowitz Jack; Solvason H Brent; Rickels Karl; Garlow Steven J; Gallop Robert J; Ninan Philip T
Coadministration of modafinil and a selective serotonin reuptake inhibitor from the initiation of treatment of major depressive disorder with fatigue and sleepiness: a double-blind, placebo-controlled study.
Journal of clinical psychopharmacology 2007;27(6):614-9.
-
2007: Rickels Karl; Robinson Donald S
Why do clinical trials fail?
Journal of clinical psychopharmacology 2007;27(4):420-1; author reply 421.
-
2006: Feiger Alan D; Rickels Karl; Rynn Moira A; Zimbroff Dan L; Robinson Donald S
Selegiline transdermal system for the treatment of major depressive disorder: an 8-week, double-blind, placebo-controlled, flexible-dose titration trial.
The Journal of clinical psychiatry 2006;67(9):1354-61.
-
2006: Brawman-Mintzer Olga; Knapp Rebecca G; Rynn Moira; Carter Rickey E; Rickels Karl
Sertraline treatment for generalized anxiety disorder: a randomized, double-blind, placebo-controlled study.
The Journal of clinical psychiatry 2006;67(6):874-81.
-
2006: Rickels Karl
Consumer advertising can be misleading.
PLoS medicine 2006;3(2):e119; author reply e116.
-
2006: Rickels Karl; Rynn Moira; Iyengar Malini; Duff David
Remission of generalized anxiety disorder: a review of the paroxetine clinical trials database.
The Journal of clinical psychiatry 2006;67(1):41-7.
-
2006: Rynn Moira; Khalid-Khan Sarosh; Garcia-Espana J Felipe; Etemad Bijan; Rickels Karl
Early response and 8-week treatment outcome in GAD.
Depression and anxiety 2006;23(8):461-5.
-
2005: Pollack Mark H; Roy-Byrne Peter P; Van Ameringen Michael; Snyder Heather; Brown Charles; Ondrasik John; Rickels Karl
The selective GABA reuptake inhibitor tiagabine for the treatment of generalized anxiety disorder: results of a placebo-controlled study.
The Journal of clinical psychiatry 2005;66(11):1401-8.
-
2005: Snyderman Steven H; Rynn Moira A; Rickels Karl
Open-label pilot study of ziprasidone for refractory generalized anxiety disorder.
Journal of clinical psychopharmacology 2005;25(5):497-9.
-
2005: Rickels Karl; Pollack Mark H; Feltner Douglas E; Lydiard R Bruce; Zimbroff Daniel L; Bielski Robert J; Tobias Kathy; Brock Jerri D; Zornberg Gwen L; Pande Atul C
Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
Archives of general psychiatry 2005;62(9):1022-30.
-
2004: Rickels Karl; Mangano Richard; Khan Arifulla
A double-blind, placebo-controlled study of a flexible dose of venlafaxine ER in adult outpatients with generalized social anxiety disorder.
Journal of clinical psychopharmacology 2004;24(5):488-96.
-
2004: Snyderman Steven H; Rynn Moira A; Bellew Kevin; Rickels Karl
Paroxetine in the treatment of generalised anxiety disorder.
Expert opinion on pharmacotherapy 2004;5(8):1799-806.
-
2004: Rickels Karl
Alprazolam extended-release in panic disorder.
Expert opinion on pharmacotherapy 2004;5(7):1599-611.
-
2004: Freeman Ellen W; Sondheimer Steven J; Rickels Karl; Martin P G
A pilot naturalistic follow-up of extended sertraline treatment for severe premenstrual syndrome.
Journal of clinical psychopharmacology 2004;24(3):351-3.
-
2004: Freeman Ellen W; Rickels Karl; Sondheimer Steven J; Polansky Marcia; Xiao Sha
Continuous or intermittent dosing with sertraline for patients with severe premenstrual syndrome or premenstrual dysphoric disorder.
The American journal of psychiatry 2004;161(2):343-51.
-
2003: Rynn Moira; García-España Felipe; Greenblatt David J; Mandos Laura A; Schweizer Edward; Rickels Karl
Imipramine and buspirone in patients with panic disorder who are discontinuing long-term benzodiazepine therapy.
Journal of clinical psychopharmacology 2003;23(5):505-8.
-
2003: Rickels Karl; Zaninelli Rocco; McCafferty James; Bellew Kevin; Iyengar Malini; Sheehan David
Paroxetine treatment of generalized anxiety disorder: a double-blind, placebo-controlled study.
The American journal of psychiatry 2003;160(4):749-56.
-
2002: Freeman Ellen W; Frye Cheryl A; Rickels Karl; Martin Paula A G; Smith Sheryl S
Allopregnanolone levels and symptom improvement in severe premenstrual syndrome.
Journal of clinical psychopharmacology 2002;22(5):516-20.
-
2002: Rickels Karl; Rynn Moira
Pharmacotherapy of generalized anxiety disorder.
The Journal of clinical psychiatry 2002;63 Suppl 14():9-16.
-
2001: Rynn M A; Siqueland L; Rickels K
Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder.
The American journal of psychiatry 2001;158(12):2008-14.
-
2001: Freeman E W; Rickels K; Yonkers K A; Kunz N R; McPherson M; Upton G V
Venlafaxine in the treatment of premenstrual dysphoric disorder.
Obstetrics and gynecology 2001;98(5 Pt 1):737-44.
-
2001: Freeman E W; Rickels K; Sondheimer S J; Polansky M
Concurrent use of oral contraceptives with antidepressants for premenstrual syndromes.
Journal of clinical psychopharmacology 2001;21(5):540-2.
-
2001: Furlan P M; DeMartinis N; Schweizer E; Rickels K; Lucki I
Abnormal salivary cortisol levels in social phobic patients in response to acute psychological but not physical stress.
Biological psychiatry 2001;50(4):254-9.
-
2001: Schweizer E; Rynn M; Mandos L A; Demartinis N; García-España F; Rickels K
The antidepressant effect of sertraline is not enhanced by dose titration: results from an outpatient clinical trial.
International clinical psychopharmacology 2001;16(3):137-43.
-
2001: Rickels K; Rynn M
Overview and clinical presentation of generalized anxiety disorder.
The Psychiatric clinics of North America 2001;24(1):1-17.
-
2001: Ballenger J C; Davidson J R; Lecrubier Y; Nutt D J; Borkovec T D; Rickels K; Stein D J; Wittchen H U
Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety.
The Journal of clinical psychiatry 2001;62 Suppl 11():53-8.
-
2001: Rickels K; Rynn M A
What is generalized anxiety disorder?
The Journal of clinical psychiatry 2001;62 Suppl 11():4-12; discussion 13-4.
-
2000: Rickels K; DeMartinis N; García-España F; Greenblatt D J; Mandos L A; Rynn M
Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy.
The American journal of psychiatry 2000;157(12):1973-9.
-
2000: Goldstein G; Fava M; Culler M; Fisher A; Rickels K; Lydiard R B; Rosenbaum J
Elevated plasma thymopoietin associated with therapeutic nonresponsiveness in major depression.
Biological psychiatry 2000;48(1):65-9.
-
2000: Rickels K; Freeman E W
Prior benzodiazepine exposure and benzodiazepine treatment outcome.
The Journal of clinical psychiatry 2000;61(6):409-13.
-
2000: Rickels K; Pollack M H; Sheehan D V; Haskins J T
Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder.
The American journal of psychiatry 2000;157(6):968-74.
-
2000: DeMartinis N; Rynn M; Rickels K; Mandos L
Prior benzodiazepine use and buspirone response in the treatment of generalized anxiety disorder.
The Journal of clinical psychiatry 2000;61(2):91-4.
-
2000: Rickels K; DeMartinis N; Aufdembrinke B
A double-blind, placebo-controlled trial of abecarnil and diazepam in the treatment of patients with generalized anxiety disorder.
Journal of clinical psychopharmacology 2000;20(1):12-8.
-
1999: Rickels K; DeMartinis N; Rynn M; Mandos L
Pharmacologic strategies for discontinuing benzodiazepine treatment.
Journal of clinical psychopharmacology 1999;19(6 Suppl 2):12S-16S.
-
1999: Freeman E W; Rickels K; Sondheimer S J; Polansky M
Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial.
Archives of general psychiatry 1999;56(10):932-9.
-
1999: Freeman E W; Rickels K
Characteristics of placebo responses in medical treatment of premenstrual syndrome.
The American journal of psychiatry 1999;156(9):1403-8.
-
1999: Rickels K; Lucki I; Schweizer E; García-España F; Case W G
Psychomotor performance of long-term benzodiazepine users before, during, and after benzodiazepine discontinuation.
Journal of clinical psychopharmacology 1999;19(2):107-13.
-
1999: Freeman E W; Rickels K; Arredondo F; Kao L C; Pollack S E; Sondheimer S J
Full- or half-cycle treatment of severe premenstrual syndrome with a serotonergic antidepressant.
Journal of clinical psychopharmacology 1999;19(1):3-8.
-
1999: Rickels K; Schweizer E; Garcia España F; Case G; DeMartinis N; Greenblatt D
Trazodone and valproate in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal symptoms and taper outcome.
Psychopharmacology 1999;141(1):1-5.
-
1998: Rickels K; Schweizer E
Panic disorder: long-term pharmacotherapy and discontinuation.
Journal of clinical psychopharmacology 1998;18(6 Suppl 2):12S-18S.
-
1998: Schweizer E; Rickels K; De Martinis N; Case G; García-España F
The effect of personality on withdrawal severity and taper outcome in benzodiazepine dependent patients.
Psychological medicine 1998;28(3):713-20.
-
1998: Schweizer E; Rickels K; Hassman H; Garcia-España F
Buspirone and imipramine for the treatment of major depression in the elderly.
The Journal of clinical psychiatry 1998;59(4):175-83.
-
1998: Rickels K; Schweizer E; Case W G; DeMartinis N; Greenblatt D J; Mandos L A; Garcia España F G
Nefazodone in major depression: adjunctive benzodiazepine therapy and tolerability.
Journal of clinical psychopharmacology 1998;18(2):145-53.
-
1998: Rickels K; Schweizer E
The spectrum of generalised anxiety in clinical practice: the role of short-term, intermittent treatment.
The British journal of psychiatry. Supplement 1998;(34):49-54.
-
1998: Schweizer E; Rickels K
Benzodiazepine dependence and withdrawal: a review of the syndrome and its clinical management.
Acta psychiatrica Scandinavica. Supplementum 1998;393():95-101.
-
1997: Rickels K; Schweizer E; DeMartinis N; Mandos L; Mercer C
Gepirone and diazepam in generalized anxiety disorder: a placebo-controlled trial.
Journal of clinical psychopharmacology 1997;17(4):272-7.
-
1997: Schweizer E; Rickels K
Placebo response in generalized anxiety: its effect on the outcome of clinical trials.
The Journal of clinical psychiatry 1997;58 Suppl 11():30-8.
-
1997: Lydiard R B; Ballenger J C; Rickels K
A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
The Journal of clinical psychiatry 1997;58 Suppl 11():11-8.
-
1997: Rickels K; Schweizer E
The clinical presentation of generalized anxiety in primary-care settings: practical concepts of classification and management.
The Journal of clinical psychiatry 1997;58 Suppl 11():4-10.
-
1997: Freeman E W; Sondheimer S J; Rickels K
Gonadotropin-releasing hormone agonist in the treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled study.
Psychopharmacology bulletin 1997;33(2):303-9.
-
1997: Schweizer E; Rickels K
Strategies for treatment of generalized anxiety in the primary care setting.
The Journal of clinical psychiatry 1997;58 Suppl 3():27-31; discussion 32-3.
-
1996: Freeman E W; DeRubeis R J; Rickels K
Reliability and validity of a daily diary for premenstrual syndrome.
Psychiatry research 1996;65(2):97-106.
-
1996: Rickels K; Derivan A; Kunz N; Pallay A; Schweizer E
Zalospirone in major depression: a placebo-controlled multicenter study.
Journal of clinical psychopharmacology 1996;16(3):212-7.
-
1996: DeMartinis N A; Schweizer E; Rickels K
An open-label trial of nefazodone in high comorbidity panic disorder.
The Journal of clinical psychiatry 1996;57(6):245-8.
-
1996: Freeman E W; Rickels K; Sondheimer S J; Wittmaack F M
Sertraline versus desipramine in the treatment of premenstrual syndrome: an open-label trial.
The Journal of clinical psychiatry 1996;57(1):7-11.
-
1996: Freeman E W; Rickels K; Sondheimer S J
Fluvoxamine for premenstrual dysphoric disorder: a pilot study.
The Journal of clinical psychiatry 1996;57 Suppl 8():56-9; discussion 60.
-
1996: Schweizer E; Rickels K
The long-term management of generalized anxiety disorder: issues and dilemmas.
The Journal of clinical psychiatry 1996;57 Suppl 7():9-12; discussion 13-4.
-
1995: Freeman E W; Schweizer E; Rickels K
Personality factors in women with premenstrual syndrome.
Psychosomatic medicine 1995;57(5):453-9.
-
1995: Freeman E W; Rickels K; Sondheimer S J; Polansky M
A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome.
JAMA : the journal of the American Medical Association 1995;274(1):51-7.
-
1995: Freeman E W; Rickels K; Schweizer E; Ting T
Relationships between age and symptom severity among women seeking medical treatment for premenstrual symptoms.
Psychological medicine 1995;25(2):309-15.
-
1995: Schweizer E; Case W G; Garcia-Espana F; Greenblatt D J; Rickels K
Progesterone co-administration in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal severity and taper outcome.
Psychopharmacology 1995;117(4):424-9.
-
1995: Rickels K; Schweizer E
Maintenance treatment studies in anxiety disorders: some methodological notes.
Psychopharmacology bulletin 1995;31(1):115-23.
-
1995: Rickels K; Robinson D S; Schweizer E; Marcus R N; Roberts D L
Nefazodone: aspects of efficacy.
The Journal of clinical psychiatry 1995;56 Suppl 6():43-6.
-
1994: Freeman E W; Rickels K; Sondheimer S J; Denis A; Pfeifer S; Weil S
Nefazodone in the treatment of premenstrual syndrome: a preliminary study.
Journal of clinical psychopharmacology 1994;14(3):180-6.
-
1994: Rickels K; Schweizer E; Clary C; Fox I; Weise C
Nefazodone and imipramine in major depression: a placebo-controlled trial.
The British journal of psychiatry : the journal of mental science 1994;164(6):802-5.
-
1994: Schweizer E; Feighner J; Mandos L A; Rickels K
Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.
The Journal of clinical psychiatry 1994;55(3):104-8.
-
1993: Rickels K; Downing R; Schweizer E; Hassman H
Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam.
Archives of general psychiatry 1993;50(11):884-95.
-
1993: Schweizer E; Patterson W; Rickels K; Rosenthal M
Double-blind, placebo-controlled study of a once-a-day, sustained-release preparation of alprazolam for the treatment of panic disorder.
The American journal of psychiatry 1993;150(8):1210-5.
-
1993: Freeman E W; Sondheimer S J; Rickels K; Albert J
Gonadotropin-releasing hormone agonist in treatment of premenstrual symptoms with and without comorbidity of depression: a pilot study.
The Journal of clinical psychiatry 1993;54(5):192-5.
-
1993: Rickels K; Schweizer E; Weiss S; Zavodnick S
Maintenance drug treatment for panic disorder. II. Short- and long-term outcome after drug taper.
Archives of general psychiatry 1993;50(1):61-8.
-
1993: Schweizer E; Rickels K; Weiss S; Zavodnick S
Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine.
Archives of general psychiatry 1993;50(1):51-60.
-
1993: Rickels K; Schweizer E
The treatment of generalized anxiety disorder in patients with depressive symptomatology.
The Journal of clinical psychiatry 1993;54 Suppl():20-3.
-
1993: Rickels K; Schweizer E
Anxiolytics: indications, benefits, and risks of short- and long-term benzodiazepine therapy: current research data.
NIDA research monograph 1993;131():51-67.
-
1992: Freeman E W; Rickels K; Sondheimer S J
Course of premenstrual syndrome symptom severity after treatment.
The American journal of psychiatry 1992;149(4):531-3.
-
1992: Rickels K; Amsterdam J; Clary C; Fox I; Schweizer E; Weise C
The efficacy and safety of paroxetine compared with placebo in outpatients with major depression.
The Journal of clinical psychiatry 1992;53 Suppl():30-2.
-
1992: Rickels K; Schweizer E; Case W G
Benzodiazepines: tolerance and withdrawal: the clinician's point of view.
Clinical neuropharmacology 1992;15 Suppl 1 Pt A():102A-103A.
-
1991: Schweizer E; Weise C; Clary C; Fox I; Rickels K
Placebo-controlled trial of venlafaxine for the treatment of major depression.
Journal of clinical psychopharmacology 1991;11(4):233-6.
-
1991: Rickels K; London J; Fox I; Hassman H; Csanalosi I; Weise C
Adinazolam, diazepam, imipramine, and placebo in major depressive disorder: a controlled study.
Pharmacopsychiatry 1991;24(4):127-31.
-
1991: Rickels K; Case W G; Schweizer E; Garcia-Espana F; Fridman R
Long-term benzodiazepine users 3 years after participation in a discontinuation program.
The American journal of psychiatry 1991;148(6):757-61.
-
1991: Schweizer E; Rickels K; Case W G; Greenblatt D J
Carbamazepine treatment in patients discontinuing long-term benzodiazepine therapy. Effects on withdrawal severity and outcome.
Archives of general psychiatry 1991;48(5):448-52.
-
1991: Rickels K; Amsterdam J D; Clary C; Puzzuoli G; Schweizer E
Buspirone in major depression: a controlled study.
The Journal of clinical psychiatry 1991;52(1):34-8.
-
1990: Rickels K; Schweizer E
Clinical overview of serotonin reuptake inhibitors.
The Journal of clinical psychiatry 1990;51 Suppl B():9-12.
-
1990: Schweizer E; Rickels K; Case W G; Greenblatt D J
Long-term therapeutic use of benzodiazepines. II. Effects of gradual taper.
Archives of general psychiatry 1990;47(10):908-15.
-
1990: Rickels K; Schweizer E; Case W G; Greenblatt D J
Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation.
Archives of general psychiatry 1990;47(10):899-907.
-
1990: Rickels K
Buspirone in clinical practice.
The Journal of clinical psychiatry 1990;51 Suppl():51-4.
-
1990: Freeman E; Rickels K; Sondheimer S J; Polansky M
Ineffectiveness of progesterone suppository treatment for premenstrual syndrome.
JAMA : the journal of the American Medical Association 1990;264(3):349-53.
-
1990: Rickels K; Schweizer E
The clinical course and long-term management of generalized anxiety disorder.
Journal of clinical psychopharmacology 1990;10(3 Suppl):101S-110S.
-
1990: Schweizer E; Pohl R; Balon R; Fox I; Rickels K; Yeragani V K
Lorazepam vs. alprazolam in the treatment of panic disorder.
Pharmacopsychiatry 1990;23(2):90-3.
-
1990: Schweizer E; Rickels K; Amsterdam J D; Fox I; Puzzuoli G; Weise C
What constitutes an adequate antidepressant trial for fluoxetine?
The Journal of clinical psychiatry 1990;51(1):8-11.
-
1990: Schweizer E; Rickels K; Csanalosi I; London J; Turner D
A placebo-controlled study of enciprazine in the treatment of generalized anxiety disorder: a preliminary report.
Psychopharmacology bulletin 1990;26(2):215-7.
-
1990: Rickels K; Amsterdam J; Clary C; Hassman J; London J; Puzzuoli G; Schweizer E
Buspirone in depressed outpatients: a controlled study.
Psychopharmacology bulletin 1990;26(2):163-7.
-
1990: Rickels K
Evaluating antidepressants and anxiolytics.
Psychopharmacology series 1990;8():3-25.
-
1990: Rickels K; Case W G; Schweizer E; Garcia-Espana F; Fridman R
Benzodiazepine dependence: management of discontinuation.
Psychopharmacology bulletin 1990;26(1):63-8.
-
1989: Schweizer E; Case W G; Rickels K
Benzodiazepine dependence and withdrawal in elderly patients.
The American journal of psychiatry 1989;146(4):529-31.
-
1989: Lucki I; Kerr L A; Fridman R B; Schweizer E; Rickels K
Behavioral effects of alprazolam in chronic therapeutic users.
NIDA research monograph 1989;95():464.
-
1989: Rickels K; Amsterdam J; Clary C; Fox I; Schweizer E; Weise C
A placebo-controlled, double-blind, clinical trial of paroxetine in depressed outpatients.
Acta psychiatrica Scandinavica. Supplementum 1989;350():117-23.
-
1988: Freeman E W; Sondheimer S J; Rickels K
Effects of medical history factors on symptom severity in women meeting criteria for premenstrual syndrome.
Obstetrics and gynecology 1988;72(2):236-9.
-
1988: Rickels K; Schweizer E; Csanalosi I; Case W G; Chung H
Long-term treatment of anxiety and risk of withdrawal. Prospective comparison of clorazepate and buspirone.
Archives of general psychiatry 1988;45(5):444-50.
-
1988: Rickels K; Fox I L; Greenblatt D J; Sandler K R; Schless A
Clorazepate and lorazepam: clinical improvement and rebound anxiety.
The American journal of psychiatry 1988;145(3):312-7.
-
1988: Rickels K; Schweizer E; Case W G
The uncontrolled case report: a double-edged sword.
The Journal of nervous and mental disease 1988;176(1):50-2.
-
1988: Schweizer E; Clary C; Weise C; Rickels K
An open-label, dose-finding study of WY-45,030, a novel bicyclic antidepressant.
Psychopharmacology bulletin 1988;24(1):195-7.
-
1988: Lucki I; Rickels K
The effect of anxiolytic drugs on memory in anxious subjects.
Psychopharmacology series 1988;6():128-39.
-
1987: Rickels K
Antianxiety therapy: potential value of long-term treatment.
The Journal of clinical psychiatry 1987;48 Suppl():7-11.
-
1987: Rickels K; Chung H R; Csanalosi I B; Hurowitz A M; London J; Wiseman K; Kaplan M; Amsterdam J D
Alprazolam, diazepam, imipramine, and placebo in outpatients with major depression.
Archives of general psychiatry 1987;44(10):862-6.
-
1987: Csanalosi I; Schweizer E; Case W G; Rickels K
Gepirone in anxiety: a pilot study.
Journal of clinical psychopharmacology 1987;7(1):31-3.
-
1986: Rickels K; Case W G; Downing R W; Fridman R
One-year follow-up of anxious patients treated with diazepam.
Journal of clinical psychopharmacology 1986;6(1):32-6.
-
1986: Rickels K; Case W G; Schweizer E E; Swenson C; Fridman R B
Low-dose dependence in chronic benzodiazepine users: a preliminary report on 119 patients.
Psychopharmacology bulletin 1986;22(2):407-15.
-
1985: Rickels K; Downing R W; Case G W; Csanalosi I; Chung H; Winokur A; Gingrich R L
Six-week trial with diazepam: some clinical observations.
The Journal of clinical psychiatry 1985;46(11):470-4.
-
1985: Rickels K; Case W G; Downing R W; Winokur A
Indications and contraindications for chronic anxiolytic treatment: is there tolerance to the anxiolytic effect?
Advances in biochemical psychopharmacology 1985;40():193-204.
-
1984: Rickels K; Case W G; Downing R W; Dixon R; Fridman R
Diazepam and desmethyldiazepam plasma concentrations in chronic anxious outpatients.
Pharmacopsychiatry 1984;17(2):44-9.
-
1983: Rickels K; Case W G; Downing R W; Winokur A
Long-term diazepam therapy and clinical outcome.
JAMA : the journal of the American Medical Association 1983;250(6):767-71.
-
1983: Rickels K; Csanalosi I; Greisman P; Cohen D; Werblowsky J; Ross H A; Harris H
A controlled clinical trial of alprazolam for the treatment of anxiety.
The American journal of psychiatry 1983;140(1):82-5.
-
1982: Rickels K; Csanalosi I; Werblowsky J; Weise C C; Weinstock R; Brown A S; Winokur A; Von Poelnitz M
Amitriptyline-perphenazine and doxepin in depressed outpatients: a controlled double-blind study.
The Journal of clinical psychiatry 1982;43(10):419-22.
-
1982: Rickels K; Weise C C; Zal H M; Csanalosi I; Werblowsky J
Lofepramine and imipramine in unipolar depressed outpatients. A placebo controlled study.
Acta psychiatrica Scandinavica 1982;66(2):109-20.
-
1982: Rickels K; Weise C C; Sandler K; Schless A; Zal M; Norstad N
Nomifensine, imipramine and placebo in depressed outpatients.
International pharmacopsychiatry 1982;17 Suppl 1():73-88.
-
1981: Rickels K; Case W G; Werblowsky J; Csanalosi I; Schless A; Weise C C
Amoxapine and imipramine in the treatment of depressed outpatients: a controlled study.
The American journal of psychiatry 1981;138(1):20-4.
-
1980: Rickels K; Csanalosi I; Greisman P; Mirman M J; Morris R J; Weise C C; Weiss G
Ketazolam and diazepam in anxiety: a controlled study.
Journal of clinical pharmacology 1980;20(10):581-9.
-
1980: Weise C C; Stein M K; Pereira-Ogan J; Csanalosi I; Rickels K
Amitriptyline once daily vs three times daily in depressed outpatients.
Archives of general psychiatry 1980;37(5):555-60.
-
1980: Stein M K; Rickels K; Weise C C
Maintenance therapy with amitriptyline: a controlled trial.
The American journal of psychiatry 1980;137(3):370-1.
Sign-in to see more